ENQUIRY
PAY FEES
ANNOUNCEMENTS
Shri Vile Parle Kelavani Mandal's
INSTITUTE OF PHARMACY, DHULE
Approved by PCI, AICTE, DTE
Affiliated to DBATU, Lonere & MSBTE Mumbai
  (02562) 297802, 297602
  iopdhule@svkm.ac.in  
Shri Vile Parle Kelavani Mandal's
INSTITUTE OF PHARMACY, DHULE
Approved by PCI, New Delhi, DTE, Mumbai, Government of Maharashtra
Affiliated to DBATU, Lonere & MSBTE Mumbai

FACULTY

Dr. Kiran D. Patil

Associate Professor

Qualification: M. Pharm., Ph.D.

Specialization: Pharmaceutics

Email ID: kiran.patil@svkm.ac.in

Phone: +91-8668782892

Experience: 10 Years

  • 08.04.2021 – Present: (1.5 years)
    Institute : Shri Vile Parle Kelavani Mandal’s Institute of Pharmacy, Dhule, MH
    Position : Associate Professor of Pharmaceutics
  • 06.09.2016 – 15.07.2020 (4 years):
    Institute : SVKM’s NMIMS, SPTM, Shirpur, MH
    Position : Lecturer Pharmaceutics
  • 01.09.2015 – 02.09.2016 (1 year):
    Institute : Gangamai College of Pharmacy, Dhule, MH
    Position : Assistant Professor of Pharmaceutics
  • 01.09.2013 – 31.08.2015 (2 years):
    Institute : Gangamai Institute of Pharmacy, Dhule, MH
    Position : Lecturer Pharmaceutics
  • 01.04.2012 – 31.08.2013 (1.5 years):
    Industry : Concept Pharmaceuticals Pvt. Ltd. Aurangabad, MH
    Position : Senior Officer
    Interest Areas: Novel Drug Delivery Systems, Targeted Drug Delivery

Research:

  • Publications:
    • International: 19
    • National: 05
  • Books: Nil
  • Book Chapters: 05
  • Patents: 02 (published)
  • Presentations:
    • International: 01
    • National: 06
  • Completed Government Funded Projects: Nil
  • Completed University Seed Grant Projects: 02
    Role: Co-Principal Investigator
    Area of Project: Formulation Development
    Name of University: NMIMS Deemed to be University, Mumbai
  • Conferences/Workshops/Seminars attended: 25

    Awards:

    • Qualified GPAT (2010) Exam Conducted by M S University, BARODA.
    • Received AICTE JRF for the duration of Master of Pharmacy.

    Professional Membership:

    • Life member of the Indian Pharmaceutical Association (MAH/DHUL/ON/LM/000273)
    • Registered Pharmacist in the Maharashtra State Pharmacy Council (139718)

    Recent Publications:

    1 Agrawal, Y.O., Husain, M., Patil, K.D., Sodgir, V., Patil, T.S., Agnihotri, V.V., Mahajan, H.S., Sharma, C., Ojha, S. and Goyal, S.N., 2022. Verapamil hydrochloride loaded solid lipid nanoparticles: Preparation, optimization, characterisation, and assessment of cardioprotective effect in experimental model of myocardial infarcted rats. Biomedicine & Pharmacotherapy, 154, p.113429. (IF- 7.419)

    2 Agrawal, Y., Patil, K., Mahajan, H., Potdar, M., Joshi, P., Nakhate, K., Sharma, C., Goyal, S.N. and Ojha, S., 2022. In vitro and in vivo characterization of Entacapone-loaded nanostructured lipid carriers developed by quality-by-design approach. Drug Delivery, 29(1), pp.1112-1121. (IF - 6.819).

    3 Mrugendra B. Potdar, Neetesh K. Jain, Kiran D. Patil., Yogeeta O. Agrawal, 2022. Development of Carmustine loaded PLGA-PEG Conjugates for Nose to Brain Targeting, Indian Journal of Pharmaceutical Education and Research, 1(1), 1-15. (IF - 0.8).

    4 Mrugendra B. Potdar, Neetesh K. Jain, Sumit S. Rathod, Kiran D. Patil., 2022. A Study on the Nose to Brain Drug Delivery System. International Journal of Pharmaceutical Sciences and Research, 13(2), 569-78.

    5 Potdar M.B, Rathod S.S, Patil K.D, Agrawal Y.O, Agnihotri V.V, Patil M.R., 2022. Formulation and Characterization of Novel Ziziphus Spina-Christi Herbal Preparation as a Hair Tonic. International Journal of Biology, Pharmacy and Allied Sciences, 11(11), 1-7.

    6 Sharma, S., Hatware, K., Bhadane, P. and Patil, K., 2021, Chemistry, Pharmacokinetics, Pharmacodynamics and Analytical methods of Bilastine, a histamine H1 receptor antagonist: An update. Mini reviews in medicinal chemistry (IF - 3.86).

    7 Patil, S., Gattani, S.G., Nirbhavane, P., Katare, O.P. and Patil, K., 2021. Quality by Design (QbD) driven Systematic Development of Nano-lipoidal Carrier of Poorly Water Soluble Anti-tubercular agent-Rifabutin. Materials Technology, pp.1-11. (IF – 3.846)

    8 Patil, K.D., Bagade, S.B. and Bonde, S.C., 2020. Biodistribution, pharmacokinetics and toxicity evaluation of mannosylated gelatin nanoparticles of linezolid for anti-tubercular therapy. Materials Technology. (IF – 3.846)

    9 Patil, K.D., Bagade, S.B. and Bonde, S.C., 2020. In-vitro and ex-vivo characterization of novel mannosylated gelatin nanoparticles of linezolid by Quality-by-Design approach. Journal of Drug Delivery Science and Technology. (IF – 5.062)

    10 Patil, K., Bagade, S., Bonde, S., 2020. QbD enabled stability indicating assay method for the estimation of Linezolid in newly developed gelatin nanoparticles for anti-tubercular therapy. Chromatographia. (IF- 2.213)

    11 Patil, S., Gattani, S., Nirbhavane, P., Patil, K. and Pal, A.K., 2020. Pharmacokinetics, Biodistribution and Toxicity Studies for Nanocarrier of Antitubercular Agent-Rifabutin. Journal of Clinical & Diagnostic Research, 14(12).

    12 Patil, S., Gattani, S.G., Nirbhavane, P., Katare, O.P. and Patil, K., 2020. Quality by design-enabled development and characterisation of nanocarrier of azithromycin. Current Medicine Research and Practice, 10(6), p.272.

    13 Hatware, K.V., Sharma, S., Patil, K., Rajput, H. and Gupta, G., 2020. Therapeutic Role of Natural Agents in the Management of Coronary Artery Disease: A Review. Journal of Environmental Pathology, Toxicology and Oncology. (IF-3.567)

    14 Sharma, S., Sharma, R., Hatware, K. and Patil, K., 2020. Review on Chemistry, Analysis, and pharmacology of teneligliptin: a novel DPP-4 inhibitor. Mini Reviews in Medicinal Chemistry. (IF- 3.86)

    15 Ketan, H., Sanjay, S., Ashwini, D., Kiran, P., Sravani, K. and Rupesh, G., 2020. Prevention of apparent adiposity by fractions of distilled cow urine: a non-invasive approach. Indian Drugs.

    16 Namita, R., Vinayakrao, H.K., Sanjay, S., Kiran, P., Sravani, K. and Kumar, G.R., 2020. Antioxidant, Sedative and Hypnotic Potential of Milk Extract of Myristica Fragrans: A Complimentary Medicine for The Management of Insomnia. Indian Drugs.

    17 Patil, K., Bagade, S., Hatware, K.V. and Sharma, S., 2019. The Potential of Herbal Constituents as New Natural Leads against Helminthiasis: A Neglected Tropical Disease. Asian Pacific Journal of Tropical Medicine, (IF- 3.041)

    18 Ravipati, E.S., Mahajan, N.N., Sharma, S., Hatware, K.V. and Patil, K., 2019. The toxicological effects of lead and its analytical trends: an update from 2000 to 2018. Critical reviews in analytical chemistry. (IF- 6.535)

    19 Karri, S., Sharma, S., Hatware, K. and Patil, K., 2019. Natural anti-obesity agents and their therapeutic role in management of obesity: A future trend perspective. Biomedicine & Pharmacotherapy, 110, pp.224-238. (IF- 7.419)

    20 Gautam, R.K., Gupta, G., Sharma, S., Hatware, K., Patil, K., Sharma, K., Goyal, S., Chellappan, D.K. and Dua, K., 2019. Rosmarinic acid attenuates inflammation in experimentally induced arthritis in Wistar rats, using Freund’s complete adjuvant. International journal of rheumatic diseases. (IF- 2.558)

    21 Sharma, S., Aware, K.S., Hatware, K. and Patil, K., 2019. Chemistry, Analysis, Pharmacokinetics and Pharmacodynamics aspects of Lorcaserin, a selective serotonin 5-HT2C receptor agonist: An update. Mini reviews in medicinal chemistry. (IF- 3.86)

    22 Patle, A., Hatware, K.V., Patil, K., Sharma, S. and Gupta, G., 2019. Role of Herbal Medicine in the Management of Urolithiasis—A Review for Future Perspectives. Journal of Environmental Pathology, Toxicology and Oncology, 38(2). (IF- 3.567)

    23 Hatware, K.V., Sharma, S., Patil, K., Shete, M., Karri, S. and Gupta, G., 2018. Evidence for gastroprotective, anti-inflammatory and antioxidant potential of methanolic extract of Cordia dichotoma leaves on indomethacin and stress induced gastric lesions in Wistar rats. Biomedicine & Pharmacotherapy, 103, pp.317-325. (IF- 7.419)

    24 Patil, K., Bagade, S., Bonde, S., Sharma, S. and Saraogi, G., 2018. Recent therapeutic approaches for the management of tuberculosis: Challenges and opportunities. Biomedicine & Pharmacotherapy, 99, pp.735-745. (IF- 7.419)

     

    Copyright 2024 SVKM's INSTITUTE OF PHARMACY. All Rights Reserved.   Privacy Policy   Terms of Use
    Admission Enquiry
    Name *
    Email *
    Mobile *
    Query / Comments *